IL10 and type 1 diabetes mellitus: We found that Ifih1R increased the overall frequency of plasma cells but decreased the frequency of IL-10 within plasma cells of non-draining lymph nodes, suggesting that Ifih1R may disrupt plasma cell composition or function that could promote inflammation during T1D.